In recent studies, alternative biomarkers such as des-γ-carboxy prothrombin (DCP), Glypican-3 (GPC-3), and Golgi protein 73 (GP73) have been utilized for the detection of HCC [37]. This evidence concerns the gene DES and hepatocellular carcinoma.